Citation

Yan R, Luo J, Lin F, Hu C, Shen S (2018) Combination of Vitamin K2 and Phosphatidylcholine Inhibits Hepatocarcinogenesis via Mir-16 Regulating. J Genet Genome Res 5:037. doi.org/10.23937/2378-3648/1410037

Copyright

© 2018 Yan R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ORIGINAL RESEARCH | OPEN ACCESS DOI: 10.23937/2378-3648/1410037

Combination of Vitamin K2 and Phosphatidylcholine Inhibits Hepatocarcinogenesis via Mir-16 Regulating

Ruicheng Yan*, Jianfei Luo, Fusheng Lin, Chao Hu, and Shiqiang Shen

Department of General Surgery, Renmin Hospital of Wuhan University, Hubei, China

Abstract

Aim

Vitamin K2 and phosphatidylcholine are two common drugs in clinical treatment. Studies carried out in the past several years demonstrated vitamin K2 and phosphatidylcholine could separately inhibit hepatocarcinogenesis. In this study, we sought to investigate the synergy of vitamin K2 and phosphatidylcholine and the potential mechanism.

Methods

Multiple assays were performed to evaluate the effect of combination administration in vitro and in vivo. Then microRNA microarray, bioinformatics analysis and western blot were performed to explore the potential mechanism of drug action.

Results

In vitro, combined administration of vitamin K2 and phosphatidylcholine for 72 hours showed significant anti-tumor effect in four HCC cell lines (Hep-3B, Hep-G2, Huh-7 and SMMC-7721). in vivo, tumor growth was signi´Čücantly suppressed in the treated group. According to microRNA microarray and bioinformatics analysis, miR-16 was significantly up-regulated and WNT signaling pathway was strongly correlated with the process of anti-tumor. Then western blot analysis indicated that low-expression of WNT3A, p-β-catenin and Bcl-2 accorded with the assumption of miR-16's function.

Conclusions

At last we inferred, given together, vitamin K2 and phosphatidylcholine exhibited synergy against hepatocarcinogenesis via miR-16 regulating. However, further study is needed to confirm these regulatory relationships.